Thiopurines/Allopurinol; Oxypurinol Interactions

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

When these two medicines are taken together, your body may not process thiopurines properly.

What might happen:

The blood levels of your thiopurine may increase and cause toxic effects such as fever, chills, easy bruising or bleeding, black or tarry stools, blood in urine, or mouth or lip sores.

What you should do about this interaction:

Contact your healthcare professionals (e.g. doctor or pharmacist) as soon as possible about taking these two medicines together. They may already be aware of this drug interaction and may be monitoring you for it. If you develop any of the symptoms above, contact your doctor. It may be necessary to adjust the dose of your medicine. Do not start, stop, or change the dosage of any medicine before checking with them first.

View Reference
  • 1.Hitchings GH. Summary of informal discussion on the role of purine antagonists. Cancer Res 1963 Sep;23:1218-25.
  • 2.Levine AS, Sharp HL, Mitchell J, Krivit W, Nesbit ME. Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children. Cancer Chemother Rep 1969 Feb;53(1):53-7.
  • 3.Nies AS, Oates JA. Clinicopathologic conference: hypertension and the lupus syndrome-- revisited. Am J Med 1971 Dec;51(6):812-4.
  • 4.Berns A, Rubenfeld S, Rymzo WT Jr, Calabro JJ. Hazard of combining allopurinol and thiopurine. N Engl J Med 1972 Mar 30;286(13):730-1.
  • 5.Zazgornik J, Kopsa H, Schmidt P, Pils P, Kuschan K, Deutsch E. Increased danger of bone marrow damage in simultaneous azathioprine- allopurinol therapy. Int J Clin Pharmacol Ther Toxicol 1981 Mar;19(3):96-7.
  • 6.Brooks RJ, Dorr RT, Durie BG. Interaction of allopurinol with 6-mercaptopurine and azathioprine. Biomed Pharmacother 1982;36(4):217-22.
  • 7.Krowka MJ, Breuer RI, Kehoe TJ. Azathioprine-associated pulmonary dysfunction. Chest 1983 Apr;83(4):696-8.
  • 8.Zimm S, Ettinger LJ, Holcenberg JS, Kamen BA, Vietti TJ, Belasco J, Cogliano-Shutta N, Balis F, Lavi LE, Collins JM, et al. Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion. Cancer Res 1985 Apr;45(4):1869-73.
  • 9.Cox GJ, Robertson DB. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Arch Dermatol 1986 Dec; 122(12):1413-4.
  • 10.Boyd IW. Allopurinol-azathioprine interaction. J Intern Med 1991 Apr; 229(4):386.
  • 11.Zimm S, Collins JM, O'Neill D, Chabner BA, Poplack DG. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther 1983 Dec; 34(6):810-7.
  • 12.Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1972. N Engl J Med 1972 Jan 27; 286(4):205-12.
  • 13.Anonymous. Hypertension and the lupus syndrome. Am J Med 1970 Oct; 49(4):519-28.
  • 14.Purinethol (mercaptopurine) US prescribing information. Gate Pharmaceuticals May, 2011.
  • 15.Imuran (azathioprine) US prescribing information. Prometheus Laboratories Inc. February, 2014.
  • 16.Duzallo (lesinurad-allopurinol) US prescribing information. Ironwood Pharmaceuticals, Inc. August 18, 2017.
  • 17.Zerra P, Bergsagel J, Keller FG, Lew G, Pauly M. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis. Pediatr Blood Cancer 2016 Apr;63(4):712-5.
  • 18.Deswal S, Srivastava A. Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review. J Clin Exp Hepatol 2017 Mar;7(1):55-62.
  • 19.Garritsen FM, van der Schaft J, de Graaf M, Hijnen DJ, Bruijnzeel-Koomen CAF, van den Broek MPH, de Bruin-Weller MS. Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema. Acta Derm Venereol 2017 Nov 14.
  • 20.Moreau B, Clement P, Theoret Y, Seidman EG. Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD. Therap Adv Gastroenterol 2017 Nov; 10(11):819-827.
  • 21.Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, Moyer AM, Evans WE, Klein TE, Antillon-Klussmann FG, Caudle KE, Kato M, Yeoh AEJ, Schmiegelow K, Yang JJ. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. Clin Pharmacol Ther 2019 May; 105(5):1095-1105.
Full Drug Information

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.